[Reproduced from memo issued to all staff of SingHealth Duke-NUS Academic Medical Centre on 13 April 2017]


13 April 2017


To: All Staff of SingHealth Duke-NUS Academic Medical Centre


Dear Colleagues,




Chief Executive Officer, Singapore General Hospital 

In the last nine years, Prof Ang Chong Lye has led the Singapore General Hospital (SGH) with his able and sterling leadership. Under his stewardship, SGH pushed the boundaries of thought leadership, pioneered bold and innovative clinical concepts, and improved work processes to deliver quality patient care and experience. Prof Ang is well-respected as a leader who walks the ground, engages staff and makes practical decisions focusing on things that truly matter to staff and patients.

A champion of informatics and analytics, he led numerous IT-related initiatives to enhance integration, safety and operational efficiency.  SGH was the pioneer in public healthcare to complete the roll-out of Electronic Medication Management, Computerised Physician Order Entry and Electronic Nurse Charting.  He has also led SGH to achieve Stage 6 in a 7-step scale of the HIMSS Analytics EMR Adoption Model for IT implementation in 2011, a significant achievement considering that less than 5% of top hospitals in the US attained Stage 7 then. 

Prof Ang’s commitment to build an integrated SGH Campus has led to new and enhanced infrastructure capacity, including the conceptualisation of the 20-year SGH Campus Masterplan that will see the landscape transform into a vibrant healthcare eco-system - integrating care, research and education to meet the nation’s future healthcare needs. In particular, he has been instrumental in planning the Outram Community Hospital (OCH), which will form an integrated part in the continuum of care, allowing patients to seamlessly transit from acute care at SGH to OCH, and eventually back to the community.    

In recognition of his contributions to healthcare, Prof Ang has been conferred several national awards, including the National Day Award, Public Admin Medal (Gold) in 2014, National Day Award (Long Service Medal) in 2012, The Leading CEO Award by the Singapore HR Awards in 2011 and National Day Award for overcoming SARS in 2003.   

On 1 May 2017, Prof Ang will relinquish his appointment as CEO, SGH after helming the Hospital for almost a decade.  We are deeply grateful to Prof Ang for his steadfast dedication and astute leadership, which has positioned SGH strategically at the leading edge of Medicine.  Prof Ang will continue to serve as Deputy Group Chief Executive Officer (Clinical Services and Informatics), SingHealth. 

Prof Kenneth Kwek, currently Deputy Chief Executive Officer (DCEO), SGH, will be appointed CEO, SGH from 1 May 2017.  On the same date, he will relinquish his appointment as CEO, KK Women’s and Children’s Hospital (KKH). 

Prof Kwek, an experienced clinician leader, inspires many with his humility and strong commitment to patient care.  Having built his career at KKH over the course of three decades, he has held several key leadership positions, including Chairman, Medical Board (CMB), KKH, Duke-NUS Senior Associate Dean, KKH Campus, and CEO, KKH.  

His commitment and exemplary leadership during his term as CEO led KKH to be recognised as the region’s top women’s and children’s hospital.  His personal conviction in Patient Safety saw many new initiatives introduced at KKH, such as the Zero Harm and Speak Up for Safety Commitment (Patient Safety A.S.A.P), the partnership with Cognitive Institute to promote high reliability and safety, and Leadership Rounding where KKH EXCO members meet with patients and staff for direct feedback on patient safety and quality.   

Prof Kwek’s contributions have led to KKH receiving numerous awards.  KKH’s Trusted Care for Pregnancy won the IT Excellence in Providing Quality of Care at the National Health IT Summit 2016, and the hospital also received the Best Innovative Use of Infocomm Technology (Public Sector) and HIMSS-Elsevier Digital Healthcare Award – Outstanding ICT Innovation Award.   

In his new role as CEO, SGH, Prof Kwek will build on the strong foundation laid by Prof Ang and continue in the pursuit of best-in-class healthcare practices with a strong culture of patient safety as the cornerstone.  He will continue the infrastructure and care delivery transformation which is well underway to ensure SGH is future-ready to meet the evolving healthcare needs.  

Chief Executive Officer, KK Women’s and Children’s Hospital 

Prof Alex Sia will succeed Prof Kenneth Kwek as CEO, KKH and will relinquish his two current appointments as CMB, KKH and Deputy Group Chairman, Medical Board (DGCMB), SingHealth with effect from 1 May 2017.  

We thank Prof Alex Sia for the many achievements during his term as CMB. He played a pivotal role in the launch of the SingHealth Duke-NUS Paediatrics Academic Clinical Programme (PAEDS ACP) and Obstetrics & Gynaecology ACP.  His leadership saw KKH's attainment of the Baby Friendly Hospital Initiative (BFHI) accreditation by WHO and UNICEF.  During his term, KKH continued to lead in many areas of healthcare for women and children, as exemplified by the establishment of an accredited chromosomal microarray analysis (CMA) diagnostic test to aid the diagnosis of genetic disorders in babies and children as well as the national centre for Non-invasive Prenatal Testing under MOH's Health Service Development Programme.

With Prof Sia's leadership, KKH developed many collaborative partnerships with external parties to improve the health for women and children, including Temasek Foundation Cares to establish the Kids 0 – 3 Centre that provides health, social, and educational services for vulnerable children aged 0 to 3 years and their mothers.  He also led KKH in the establishment of the VIVA-KKH Paediatric Brain and Solid Tumour programme in partnership with VIVA Foundation for Children with Cancer and St Jude Children’s Research Hospital, USA. 

As DGCMB, SingHealth, Prof Sia supported GCMB, SingHealth in championing excellence in clinical service, teaching and research across the cluster.  He also provided strategic leadership to the SingHealth Medical Board (SMB) and assisted GCMB in supporting the SingHealth Duke-NUS Disease Centres in the drive to deliver seamless, multi-disciplinary person-centric care with the best clinical outcomes and experience. 

In his new role as CEO, KKH, Prof Sia will continue KKH's pursuit as the healthcare leader for women and children.  He will continue to strengthen the culture of academic medicine and the drive to target zero harm for our patients.   

Chairman, Medical Board, KK Women’s and Children’s Hospital and Duke-NUS Senior Associate Dean, KKH Campus  

Adj Assoc Prof Ng Kee Chong will assume the role of CMB, KKH.  This is concurrent to his role as Duke-NUS Senior Associate Dean, KKH Campus. He will relinquish his role as Chairman, Division of Medicine, KKH and Academic Chair, PAEDS ACP.  

During his term as Chair of the Division of Medicine, KKH, he restructured and managed the smooth transition of leadership of several departments and service units within the Division.  He also established the Tan Cheng Lim Research & Education Fund under PAEDS ACP, as well as the Tan Cheng Lim-CCF Professorship in Paediatric Oncology, advancing clinical research and education in paediatric medicine. 

In 2013, he helped Professor Salvatore Albani, a world-renowned paediatric rheumatologist and clinician translational scientist, set up the SingHealth Translational Immunology & Inflammation Centre (STIIC) at Academia under SingHealth and PAEDS ACP.  Partnering with Temasek Foundation Cares, he spearheaded the setting up of the Temasek Foundation Cares Trauma Network for Children to provide community-based therapy to children experiencing trauma-related emotional and psychological difficulties.  

He currently serves as a paediatric taskforce member of the International Liaison Committee on Resuscitation (ILCOR) and is a member of the MOH National Resuscitation Council (NRC).  He also plays an active role in the MOH National Trauma Committee. 

Adj Assoc Prof Ng has been active in humanitarian projects in various countries, including setting up KKH’s Regional Disaster Outreach Programme.  He also co-led the Singapore International Foundation-sponsored Paediatric Emergency training program in Cambodia, Laos and Myanmar.   

Chairman, Division of Medicine, KK Women’s and Children’s Hospital and Academic Chair, SingHealth Duke-NUS Paediatrics Academic Clinical Programme 

Adj Asst Prof Chan Yoke Hwee will be appointed Chairman, Division of Medicine, KKH. A dedicated paediatric intensivist and Head of Paediatric ICU at KKH, she will be concurrently appointed Academic Chair, PAEDS ACP.  In her new role as Chairman, Division of Medicine, KKH and Academic Chair of PAEDS ACP, Adj Asst Prof Chan will provide leadership to the Division of Medicine in KKH and harness the synergies of clinical services, research and education to improve patient care. 


Adj Asst Prof Chan pioneered and set up Singapore’s first Paediatric Home Care Service more than 16 years ago and was also responsible for the Paeds ECMO programme in KKH and a training programme to enable the upskilling of our ICU nurses to take on the daunting task of ECMO specialists which is traditionally done by perfusionists. She is active in education and is a member of the Organising Committee for the 2018 World Federation of Paediatric Critical and Intensive Care Conference (WFPICC) that will be held in Singapore.

Deputy Group Chairman, Medical Board, SingHealth 

Assoc Prof Ng Wai Hoe will be appointed Deputy Group Chairman, Medical Board, SingHealth, concurrent to his appointment as Medical Director, National Neuroscience Institute with effect from 1 May 2017.  

In his new role, Assoc Prof Ng will assist Group Chairman, Medical Board in providing medical leadership to champion excellence in clinical service, teaching and education across the cluster. 


Please join us in extending heartfelt appreciation to Prof Ang Chong Lye for his dedication, visionary leadership and contributions to SGH.  We congratulate Prof Kenneth Kwek, Prof Alex Sia, Adj Assoc Prof Ng Kee Chong, Adj Asst Prof Chan Yoke Hwee and Assoc Prof Ng Wai Hoe on their new leadership appointments and trust that you will extend your full support to ensure their continued success.  


Warmest regards, 

Professor Ivy Ng

Group Chief Executive Officer


Professor Thomas Coffman


Duke-NUS Medical School

Copyright © 2013. All rights reserved.